Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...

There's a new pill and new ways to pay for the weight-loss drugs known as GLP-1s. Scott Detrow is a White House correspondent for NPR and co-hosts the NPR Politics Podcast.

Danish pharmaceutical firm Novo Nordisk A/S (NYSE:NVO) scored a major win earlier this month after it secured the Food and ...

Family physician shares weight loss tips for 2026 from 41NBC News | WMGT-DT Dr. Patel says weight loss is about more than ...

The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

With Americans focused on getting fit in the new year, a groundbreaking new option is set to shift the weight loss landscape ...

The U.S. Food and Drug Administration has approved the first pill version of a GLP-1 drug for weight loss, a move that could ...

With appetite suppressing pills about to flood the market, restaurants and food companies are scrambling to adapt.

The FDA has approved the first GLP-1 pill for weight loss and it's expected in pharmacies in the coming weeks. Dr. Holly ...

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.